Adding Rituximab to Standard Care May Prolong Lymphoma Survival

WEDNESDAY, Sept. 27, 2017 -- Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds. The disease, known as mantle-cell lymphoma, is generally...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news